Lamotrigine

Clinical Chemistry

---

Description

---

Indications

Lamotrigine theraepeutic drug monitoring (TDM) has several indications including assessment of the adequacey of a dose, avoidance of toxicity, investigation of suspected malabsorption, and assessment of adherence.

---

Sample Type

Serum (SST/gel) or plasma (lithium heparin) 1 mL minimum. Serum/plasma should be aliquotted immediately following centrifugation of sample tubes containg separator gels.

---

Reference Range

Reference ranges are provided on the report. Alternatively, please contact the laboratory for current ranges.

---

Turnaround Time

Within 8 days

---

Testing Frequency

Weekly

---

External Notes

Proprietary name Lamictal

---

Patient Preparation

Timing of sample is not critical where steady state is achieved but pre-dose (trough) sample preferable.

---

Please note: the above information is subject to change and we endeavour to keep this website up to date wherever necessary.